Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark studyHesham Eissa, Luigi D. Notarangelo, Roberta Parrott et al.|Journal of Allergy and Clinical Immunology|2023Cited by 21
High event-free (EFS) and overall survival (OS) after non-total body irradiation (TBI) conditioning and allogeneic hematopoietic cell transplantation (HCT) in next-generation-sequencing minimal residual disease (NGS-MRD) negative B-acute lymphoblastic leukemia (B-ALL): Results from the EndRAD trial (PTCTC ONC1701)Hisham Abdel-Azim, Michael A. Pulsipher, Troy C. Quigg et al.|Blood|2025Cited by 2
Bone marrow next generation sequencing minimal residual disease (NGS-MRD) positivity pre-allogeneic hematopoietic cell transplantation (HCT) predicts outcomes for patients with B-cell acute lymphoblastic leukemia (B-ALL): A planned analysis from the ptctc ONC1401 trialAmanda Johnson, Hisham Abdel-Azim, Yuxin Zhao et al.|Blood|2025Cited by 0